Affordable Access

Primary targeting of recombinant Fv-immunotoxin hscFv(25)-mTNFalpha against hepatocellular carcinoma.

Authors
  • Zhang, Jing
  • Liu, Yan-Fang
  • Yang, Shou-Jing
  • Qiao, Qing
  • Cheng, Hong
  • Zhang, Chuan-Shan
  • Ma, Fu-Cheng
  • Guo, Hua-Zhang
Type
Published Article
Journal
World Journal of Gastroenterology
Publisher
Baishideng Publishing Group Co
Publication Date
Jul 01, 2004
Volume
10
Issue
13
Pages
1872–1875
Identifiers
PMID: 15222026
Source
Medline
License
Unknown

Abstract

Recombinant Fv-immunotoxin hscFv(25)-mTNFalpha has better therapeutic effect than mTNFalpha. It can inhibit the cellular growth of HCC and has some potential of clinical application.

Report this publication

Statistics

Seen <100 times